Dysregulation of the autophagy-endolysosomal system in amyotrophic lateral sclerosis and related motor neuron diseases
- PMID: 22852081
- PMCID: PMC3407648
- DOI: 10.1155/2012/498428
Dysregulation of the autophagy-endolysosomal system in amyotrophic lateral sclerosis and related motor neuron diseases
Abstract
Amyotrophic lateral sclerosis (ALS) is a heterogeneous group of incurable motor neuron diseases (MNDs) characterized by a selective loss of upper and lower motor neurons in the brain and spinal cord. Most cases of ALS are sporadic, while approximately 5-10% cases are familial. More than 16 causative genes for ALS/MNDs have been identified and their underlying pathogenesis, including oxidative stress, endoplasmic reticulum stress, excitotoxicity, mitochondrial dysfunction, neural inflammation, protein misfolding and accumulation, dysfunctional intracellular trafficking, abnormal RNA processing, and noncell-autonomous damage, has begun to emerge. It is currently believed that a complex interplay of multiple toxicity pathways is implicated in disease onset and progression. Among such mechanisms, ones that are associated with disturbances of protein homeostasis, the ubiquitin-proteasome system and autophagy, have recently been highlighted. Although it remains to be determined whether disease-associated protein aggregates have a toxic or protective role in the pathogenesis, the formation of them results from the imbalance between generation and degradation of misfolded proteins within neuronal cells. In this paper, we focus on the autophagy-lysosomal and endocytic degradation systems and implication of their dysfunction to the pathogenesis of ALS/MNDs. The autophagy-endolysosomal pathway could be a major target for the development of therapeutic agents for ALS/MNDs.
Figures
Similar articles
-
Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice.Hum Mol Genet. 2016 Aug 1;25(15):3321-3340. doi: 10.1093/hmg/ddw180. Epub 2016 Jul 20. Hum Mol Genet. 2016. PMID: 27439389
-
Alteration of protein folding and degradation in motor neuron diseases: Implications and protective functions of small heat shock proteins.Prog Neurobiol. 2012 May;97(2):83-100. doi: 10.1016/j.pneurobio.2011.09.009. Epub 2011 Sep 29. Prog Neurobiol. 2012. PMID: 21971574 Review.
-
Defects in optineurin- and myosin VI-mediated cellular trafficking in amyotrophic lateral sclerosis.Hum Mol Genet. 2015 Jul 1;24(13):3830-46. doi: 10.1093/hmg/ddv126. Epub 2015 Apr 9. Hum Mol Genet. 2015. PMID: 25859013
-
The ALS-linked E102Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins.Cell Death Differ. 2017 Oct;24(10):1655-1671. doi: 10.1038/cdd.2017.88. Epub 2017 Jun 16. Cell Death Differ. 2017. PMID: 28622300 Free PMC article.
-
Causative Genes in Amyotrophic Lateral Sclerosis and Protein Degradation Pathways: a Link to Neurodegeneration.Mol Neurobiol. 2018 Aug;55(8):6480-6499. doi: 10.1007/s12035-017-0856-0. Epub 2018 Jan 10. Mol Neurobiol. 2018. PMID: 29322304 Review.
Cited by
-
Biased signaling by thyroid-stimulating hormone receptor-specific antibodies determines thyrocyte survival in autoimmunity.Sci Signal. 2018 Jan 23;11(514):eaah4120. doi: 10.1126/scisignal.aah4120. Sci Signal. 2018. PMID: 29363585 Free PMC article.
-
Interruption of endolysosomal trafficking leads to stroke brain injury.Exp Neurol. 2021 Nov;345:113827. doi: 10.1016/j.expneurol.2021.113827. Epub 2021 Aug 5. Exp Neurol. 2021. PMID: 34363809 Free PMC article.
-
Impaired Mitophagy Plays a Role in Denervation of Neuromuscular Junctions in ALS Mice.Front Neurosci. 2017 Aug 25;11:473. doi: 10.3389/fnins.2017.00473. eCollection 2017. Front Neurosci. 2017. PMID: 28890682 Free PMC article.
-
Concomitant gain and loss of function pathomechanisms in C9ORF72 amyotrophic lateral sclerosis.Life Sci Alliance. 2021 Feb 22;4(4):e202000764. doi: 10.26508/lsa.202000764. Print 2021 Apr. Life Sci Alliance. 2021. PMID: 33619157 Free PMC article.
-
Insights of Endocytosis Signaling in Health and Disease.Int J Mol Sci. 2023 Feb 3;24(3):2971. doi: 10.3390/ijms24032971. Int J Mol Sci. 2023. PMID: 36769293 Free PMC article. Review.
References
-
- Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nature Reviews Neurology. 2011;7(11):603–615. - PubMed
-
- Hardiman O, van den Berg LH, Kiernan MC. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nature Reviews Neurology. 2011;7(11):639–649. - PubMed
-
- Gordon PH, Meininger V. How can we improve clinical trials in amyotrophic lateral sclerosis? Nature Reviews Neurology. 2011;7(11):650–654. - PubMed
-
- Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nature Reviews Neurology. 2011;7(11):616–630. - PubMed
-
- Swarup V, Julien JP. ALS pathogenesis: recent insights from genetics and mouse models. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2011;35(2):363–369. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous